Overview
🌐 Website:
💲 Revenue:
📍 Address:
👥 Employees:
🗓️ Established: 2010
📅 Published: September 28, 2025
✏️ Last updated: June 20, 2026
🌐 Website:
💲 Revenue:
📍 Address:
👥 Employees:
🗓️ Established: 2010
📅 Published: September 28, 2025
✏️ Last updated: June 20, 2026
AskAI Summary of BCAL Diagnostics Limited
Generated using ISVWorld's AskAI proprietary software industry model.
📝 AskAI Recap: An Australian biotechnology company developing and commercializing BREASTESTplus™, a first-in-class non-invasive blood test software product designed to complement mammograms for early breast cancer screening.
💬 Inclusion Rationale: BCAL Diagnostics develops and commercializes a diagnostic software product (BREASTESTplus™) which is a non-invasive blood test designed to complement existing breast cancer screening methods. This diagnostic test involves proprietary technology and software supported by a NATA-accredited lab infrastructure. The company clearly develops and sells a software-based diagnostic product, qualifying it as an ISV rather than just a service provider or custom solution developer.